Not exact matches
A randomized, blinded, placebo - controlled pivotal field study to evaluate the effectiveness and safety of
robenacoxib (tablets) when administered at a dose of 2 mg / kg once daily for 3 days for the control of postoperative pain and inflammation associated with soft - tissue surgery
in dogs.
Subcutaneous administration of Onsior (
robenacoxib) injection at a dose of 2 mg / kg (0.91 mg / lb) once daily for up to 3 days, with the first dose administered approximately 45 minutes prior to surgery, was effective and well - tolerated for the control of postoperative pain and inflammation with soft - tissue surgery
in dogs.
The active ingredient
in Onsior is
robenacoxib.
Onsior ® (
robenacoxib) injection is indicated for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration
in cats ≥ 4 months of age; for up to a maximum of 3 days.
Do not use
in cats that have hypersensitivity to
robenacoxib or known intolerance to NSAIDs.
In the United States, there is one NSAID approved for up to three days use in cats to control pain associated with surgery: ONSIOR (robenacoxib) tablets or ONSIOR (robenacoxib) injectio
In the United States, there is one NSAID approved for up to three days use
in cats to control pain associated with surgery: ONSIOR (robenacoxib) tablets or ONSIOR (robenacoxib) injectio
in cats to control pain associated with surgery: ONSIOR (
robenacoxib) tablets or ONSIOR (
robenacoxib) injection.